Category: Q3
Analogic Corp.'s first-quarter sales and earnings slide, but its medical technology business turns it around, it settles a dispute with activist investor group Ramius LLC and inks a security deal with Smiths Detection.
Analogic Corp. (NSDQ:ALOG) posted lower sales and earnings during the first quarter, but its medical technology business clawed its way toward last year's levels. Analogic also settled a dispute with an activist investor group and inked a new deal for its security business.
The Peabody, Mass.-based imaging equipment maker posted sales of $95.4 million for the three months ended Oct. 31, down 6.1 percent compared with $101.6 million during the same period last year. Net income plummeted 91.9 percent to $26 million, from $320 million during Q1 2009.
The Little Falls, N.J.-based infection prevention and control products maker makes first-quarter gains as revenues rise 10 percent and net income soars 85 percent.
Cantel Medical Corp. (NYSE:CMN) posted first-quarter sales of $71 million for the three months ended Oct. 31, up 10.2 percent compared with $64.4 million during the same period last year. Net income rose 85 percent to $6.2 million, compared with $3.3 million during Q3 2008:
Press Release
Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase
The British retinal imaging firm's fiscal 2009 sales slip 4 percent as it posts a net loss of $4.3 million for the year.
Sales for Optos plc (LSE:OPTS) slid 3.6 percent during fiscal 2009, to $97.2 million, but its strategy to boost pay-per-patient revenues continued to gain traction even as it posted a net loss for the year.
The British retinal imaging firm, which has operations in Marlborough, Mass., said its pay-per-patient revenues for the fiscal year ended Sept. 30 rose 2 percent to $93.5 million, compared with $91.7 million during the same period last year, as it developed its strategy to shift from large capital equipment sales.
Medtronic Inc.'s second-quarter sales rose 8 percent and Q2 net earnings surged 60 percent, prompting it to raise its earnings guidance for the full year.
Medtronic Inc. (NYSE:MDT) posted net earnings of $868 million on sales of $3.84 billion during the second quarter, compared with net earnings of $547 million in $3.57 billion in sales during the same period last year.
Outside the U.S., sales grew 12 percent to $1.54 billion, or 40 percent of total revenues.
The Minneapolis-based medical device monolith said its Q2 2010 results for the three months ended Oct. 30 were strong enough for it to upgrade its earnings guidance for the full year. Medtronic said it expects diluted earnings-per-share of between $3.17 and $3.22 for fiscal 2010, up from its previous forecast of $3.10 to $3.20.
The Milford, Mass.-based life sciences service provider posts its second profitable quarter in a row as it closes out the year, but full-year net losses still widen.
SeraCare Life Sciences Inc. (SRLS) posted its second profitable quarter in a row to close out fiscal 2009, but net losses for the full year still widened by nearly 30 percent.
The Milford, Mass.-based life sciences service provider reported sales of $12.5 million during the three months ended Sept. 30, up 9.5 percent compared with $11.4 million during the same period last year. Fourth-quarter net income was $1.4 million, compared with a net loss of $10.4 million during Q4 2008.
The St. Paul, Minn.-based medical device maker posted sales of $15.2 million during the first quarter of fiscal 2010 and cut its Q1 net losses by more than 50 percent.
Cardiovascular Systems Inc. (CSI) posted first-quarter sales of $15.2 million for the three months ended Sept. 30, up 30.5 percent compared with $11.6 million during the same period last year. The St. Paul, Minn.-based cardiovascular device maker narrowed its net losses from $13.7 million during the first quarter of fiscal 2009 to $6.2 million during Q1 2010:
Press Release
Cardiovascular Systems Reports Fiscal First-Quarter 2010 Financial Results
First-Quarter Net Loss Improves 55 Percent Over Prior Year on 30-Percent Revenue Increase, Gross Margin Improvements and Expense Control
The Farmingdale, N.Y.-based ultrasound device maker's sales slide during the first quarter of fiscal 2010 as it posts a net loss for the quarter.
Misonix Inc. (MSON) posted first-quarter sales of $2.7 million for the three months ended Sept. 30, down 12.6 percent compared with $3.1 million during the same period last year. The Farmingdale, N.Y.-based ultrasound device maker swung into the red for Q1 2010, posting a net loss of $776,000 compared with net income of $320,000 during Q1 2009:
Press Release
Misonix Reports First Quarter Fiscal 2010 Financial Results
